{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:04:39Z","timestamp":1788887079449,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.3816\/ccc.2009.n.026","type":"journal-article","created":{"date-parts":[[2009,7,25]],"date-time":"2009-07-25T21:06:12Z","timestamp":1248555972000},"page":"163-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Delayed Reversible Posterior Encephalopathy Syndrome Following Chemotherapy with Oxaliplatin"],"prefix":"10.3816","volume":"8","author":[{"given":"Ubaidullah","family":"Sharief","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CCC.2009.n.026_bib1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior Leukoencephalopathy syndrome","volume":"334","author":"Hinchey","year":"1996","journal-title":"N Engl J Med"},{"key":"10.3816\/CCC.2009.n.026_bib2","first-page":"205","article-title":"Clinical spectrum of reversible posterior leukoencephalopathy syndrome","volume":"65","author":"Lee","year":"2008","journal-title":"Arch Neurol"},{"key":"10.3816\/CCC.2009.n.026_bib3","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1212\/01.wnl.0000269780.45472.16","article-title":"Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome","volume":"69","author":"Kozak","year":"2007","journal-title":"Neurology"},{"key":"10.3816\/CCC.2009.n.026_bib4","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/archneur.1988.00520340032007","article-title":"Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions","volume":"45","author":"Hauser","year":"1988","journal-title":"Arch Neurol"},{"key":"10.3816\/CCC.2009.n.026_bib5","first-page":"1038","article-title":"Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images","volume":"23","author":"Covarrubias","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.3816\/CCC.2009.n.026_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2214\/ajr.166.3.8623651","article-title":"Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity","volume":"166","author":"Appignani","year":"1996","journal-title":"AJR Am J Roentgenol"},{"key":"10.3816\/CCC.2009.n.026_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ana.410400406","article-title":"Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506)","volume":"40","author":"Small","year":"1996","journal-title":"Ann Neurol"},{"key":"10.3816\/CCC.2009.n.026_bib8","first-page":"651","article-title":"MR imaging of reversible cyclosporin Ainduced neurotoxicity","volume":"12","author":"Truwit","year":"1991","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.3816\/CCC.2009.n.026_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00007890-200002270-00001","article-title":"Immunosuppressive-associated leukoencephalopathy in organ transplant recipients","volume":"69","author":"Singh","year":"2000","journal-title":"Transplantation"},{"key":"10.3816\/CCC.2009.n.026_bib10","doi-asserted-by":"crossref","first-page":"29669","DOI":"10.1074\/jbc.M204519200","article-title":"Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A","volume":"277","author":"Kou","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3816\/CCC.2009.n.026_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0005-2728(98)00114-5","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"1366","author":"Beal","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.3816\/CCC.2009.n.026_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1124\/mi.4.2.7","article-title":"Biochemical mechanisms of cyclosporine neurotoxicity","volume":"4","author":"Serkova","year":"2004","journal-title":"Mol Interv"},{"key":"10.3816\/CCC.2009.n.026_bib13","first-page":"415","article-title":"Cisplatin Neurotoxicity presenting as Reversible Posterior Leukoencephalopathy Syndrome","volume":"19","author":"Ito","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.3816\/CCC.2009.n.026_bib14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/annonc\/mdl436","article-title":"Reversible posterior Leukoencephalopathy syndrome after carboplatin therapy","volume":"18","author":"Vieillot","year":"2007","journal-title":"Ann Oncol"},{"key":"10.3816\/CCC.2009.n.026_bib15","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJMc052954","article-title":"Reversible posterior leukoencephalopathy syndrome and bevacizumab","volume":"354","author":"Ozcan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.3816\/CCC.2009.n.026_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajh.20147","article-title":"Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies","volume":"77","author":"Tam","year":"2004","journal-title":"Am J Hematol"},{"key":"10.3816\/CCC.2009.n.026_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00004728-198903000-00023","article-title":"MR demonstration of reversible brain abnormalities in eclampsia","volume":"13","author":"Schwaighofer","year":"1989","journal-title":"J Comput Assist Tomogr"},{"key":"10.3816\/CCC.2009.n.026_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1552-6569.2004.tb00223.x","article-title":"Neuroimaging in Posterior Reversible Encephalopathy Syndrome","volume":"14","author":"Lamy","year":"2004","journal-title":"J Neuroimaging"},{"key":"10.3816\/CCC.2009.n.026_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2214\/ajr.162.3.8109519","article-title":"Acute hypertensive encephalopathy: findings on spin-echo and gradient-echo MR imaging","volume":"162","author":"Weingarten","year":"1994","journal-title":"AJR Am J Roentgenol"},{"key":"10.3816\/CCC.2009.n.026_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1445-5994.2004.00750.x","article-title":"Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed","volume":"35","author":"Stott","year":"2005","journal-title":"Intern Med J"},{"key":"10.3816\/CCC.2009.n.026_bib21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s004150050360","article-title":"Cyclosporine neurotoxicity: a review","volume":"246","author":"Gijtenbeek","year":"1999","journal-title":"J Neurol"},{"key":"10.3816\/CCC.2009.n.026_bib22","first-page":"386","article-title":"A case of oxaliplatin-related posterior reversible encephalopathy syndrome","volume":"6","author":"Skelton","year":"2007","journal-title":"Clin Colorectal Cancer"},{"key":"10.3816\/CCC.2009.n.026_bib23","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1200\/JCO.2007.13.5954","article-title":"Reversible Posterior Leukoencephalopathy Syndrome Associated With Oxaliplatin","volume":"25","author":"Pinedo","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002811703656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002811703656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:59:39Z","timestamp":1761519579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002811703656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1533002811703656"],"URL":"https:\/\/doi.org\/10.3816\/ccc.2009.n.026","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed Reversible Posterior Encephalopathy Syndrome Following Chemotherapy with Oxaliplatin","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CCC.2009.n.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}